Role of Inferior Colliculi in Auditory Hallucinations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorCentre Hospitalier Universitaire de Nīmes

About this trial

The neural basis of auditory hallucinations (AH) in patients with schizophrenia is poorly characterized. Functional imaging studies investigate either the "state" dimension (i.e., the measurement of changes in brain area activation at the precise moment of AH onset) or the "trait" dimension (i.e., the neural correlates of the propensity to hallucinate). A corollary of AH (particularly acoustic-verbal) is the activation of brain regions involved in the auditory perception of speech (auditory cortex). One theory is that patients with schizophrenia with AH may have a deficit in processing their internal speech (i.e., external attribution to internal verbal content). However, there is little clinical data on the specific role of the mesencephalic region of the inferior colliculi (IC) in the formation of these symptoms. Preliminary research has shown intense expression of dopamine D2 receptors, particularly on glutamatergic neurons in mouse ICs. Thus, ICs receive numerous inhibitory dopaminergic inputs, likely involved in signal optimization and modulation. The study authors hypothesize that AHs are the result of a defect in signal inhibition by the IC, which lose their function as perceptual filters.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The patient must have given their free and informed consent and signed the consent form

The patient must be a member or beneficiary of a health insurance plan

DSM-5 diagnosis of schizophrenic disorder (based on clinical assessment and confirmed by the MINI 7.0 interview)

Patient with a schizophrenic disorder lasting ≤ 20 years

Disqualifiers

The patient is under safeguard of justice or state guardianship

Contraindications to magnetic resonance imaging, including severe claustrophobia, based on clinical judgment.

Congenital or acquired deafness

Suicide risk, based on clinical judgment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Unenhanced brain MRI

    Other intervention

    Unenhanced brain MRI in five sequences: 1) T1-weighted anatomical sequences 2) Resting-state functional sequences 3) Task-based functional sequence 4) Structural sequence using Diffusion Tensor Imaging (DTI) 5) Routine magnetic resonance spectroscopy sequence

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Patient Group (SCZ+/AH+)Experimental treatment 1 intervention
Group B: Control Group (SCZ+/AH-)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Resting state of functional connectivity of the inferior colliculi region with other regions of the auditory network between groups

Measured by MRI

Time frame
Day 0
2

Default mode network patterns between groups

Measured by MRI

Time frame
Day 0

Secondary outcomes

1

Neuronal activation in the ICs during exposure to auditory stimuli between groups

Difference in the blood-oxygen level dependent (BOLD) signal measured by functional MRI during an auditory stimulus exposure paradigm in the IC region

Time frame
Day 0
2

Per-auditory activation in other brain areas between groups

Difference in the BOLD signal measured by functional MRI in other brain areas

Time frame
Day 0
3

IC metabolite composition between the groups

Difference in the peak magnetic resonance spectrometry (sMRI) signal

Time frame
Day 0
4

Structural connectivity via white matter between ICs and other auditory network structures between groups

Difference in structural connectivity using DTI (diffusion tensor imaging, anisotropy fraction calculation, mean diffusivity, and tractography) from the ICs

Time frame
Day 0

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.